BU
GMED icon

BBVA USA’s Globus Medical GMED Stock Holding History

BBVA USA’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$144K Buy
+1,880
New +$151K 0.01% 492

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

BBVA USA's GMED Position: Q3 2021 in Review

BBVA USA opened a new position in Globus Medical (GMED) in Q3 2021: 1,880 shares worth $144K. The stake represents 0.01% of the portfolio and ranks #492 among its holdings.

388 funds tracked by Wall St. Rank hold GMED as of Q3 2021.

  • BBVA USA held 1,880 shares of Globus Medical worth $144K as of Q3 2021.
  • Globus Medical was a new BBVA USA position in Q3 2021.
  • Globus Medical made up 0.01% of BBVA USA's portfolio in Q3 2021, its #492 holding.
  • 388 funds tracked by Wall St. Rank held Globus Medical as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.